<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="6452" whole_study_id="5387" phs="000021" v="3" p="2" createDate="2010-10-22T12:25:02-05:00" completedByGPADate="2014-09-11T13:29:23-05:00" modDate="2021-02-12T09:04:29-05:00" maxParentChildStudyModDate="2021-02-12T09:04:29-05:00" handle="GAIN_Schizophrenia" num_participants="5066"><StudyInfo accession="phs000021.v3.p2" parentAccession="phs000021.v3.p2"><BioProject id="PRJNA75797" entrez_id="75797" type="bp_admin_access"/><BioProject id="PRJNA75799" entrez_id="75799" type="bp_data_submission"/><StudyNameReportPage>http://www.fnih.org/index.php?option=com_content&amp;task=view&amp;id=338&amp;Itemid=454</StudyNameReportPage><StudyNameEntrez>GAIN: Genome-Wide Association Study of Schizophrenia</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType></StudyTypes><Description>
&lt;p&gt;The goal of the study is to find susceptibility genes for schizophrenia.&lt;/p&gt;      &lt;p&gt;&lt;b&gt;Dataset versioning&lt;/b&gt;&lt;br/&gt;    &lt;ul&gt;   &lt;li&gt;Version 1: European-American (EA) ancestry only&lt;/li&gt;   &lt;li&gt;Version 2: Version 1 plus African-American (AA) ancestry&lt;/li&gt;    &lt;/ul&gt;    &lt;/p&gt;    &lt;p&gt;&lt;b&gt;Consent groups and participant set&lt;/b&gt;&lt;br/&gt;  &lt;ul&gt;      &lt;li&gt;General research use (GRU):  4591 cases and controls (1217 EA cases, 1442 EA controls, 953 AA cases, 979 AA controls)&lt;br/&gt;      This consent group includes a subset of schizophrenia cases and all controls (which overlap with Bipolar study controls      in Bipolar: GRU dataset).&lt;/li&gt;   &lt;li&gt;Schizophrenia and related disorders (SARC): 475 cases (187 EA cases, 288 AA cases)&lt;br/&gt;      This consent group includes a subset of schizophrenia cases.&lt;/li&gt;  &lt;/ul&gt;    &lt;/p&gt;
 </Description><Attributions><Header title="Lead Principal Investigator and Clinical Site PI"><AttrName>Pablo V. Gejman, MD</AttrName><Institution>NorthShore University HealthSystem (NUH), Evanston, IL, USA</Institution></Header><Header title="Statistical Task Force Chair, Clinical Site PI, Clinical Database"><AttrName>Douglas F. Levinson, MD</AttrName><Institution>Stanford University School of Medicine, Palo Alto, CA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Farooq Amin, MD</AttrName><Institution>Emory University, Atlanta, GA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Donald W. Black, MD</AttrName><Institution>University of Iowa Hospitals and Clinics, Iowa City, IA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Nancy G. Buccola, APRN., CNS-BC</AttrName><Institution>Louisiana State University Health Services Center, New Orleans, LA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>William F. Byerley, MD</AttrName><Institution>University of San Franciso, San Francisco, CA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>C. Robert Cloninger, MD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Robert Freedman, MD</AttrName><Institution>University of Colorado Health Sciences Center, Denver, CO, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Bryan J. Mowry, MD</AttrName><Institution>Queensland Centre for Mental Health Research, Queensland, Australia</Institution></Header><Header title="Clinical Site PI"><AttrName>Jeremy M. Silverman, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, New York, USA</Institution></Header><Header title="Statistician"><AttrName>Frank Dudbridge, PhD</AttrName><Institution>University of Cambridge, Institute of Public Health, Cambridge, UK</Institution></Header><Header title="Statistician"><AttrName>Peter A. Holmans, PhD</AttrName><Institution>Wales College of Medicine, Cardiff University, Cardiff, Wales, UK</Institution></Header><Header title="Statistician"><AttrName>Maria Martinez, PhD</AttrName><Institution>Institut National de la Sant&#233; et de la Recherche M&#233;dicale (INSERM), Toulouse, France</Institution></Header><Header title="Statistician"><AttrName>Itsik Pe'er, PhD</AttrName><Institution>Columbia University, New York, NY, USA</Institution></Header><Header title="Statistician"><AttrName>Jianxin Shi, PhD</AttrName><Institution>Stanford University School of Medicine, Palo Alto, CA, USA</Institution></Header><Header title="Statistician"><AttrName>Alice Whittemore, PhD</AttrName><Institution>Stanford University School of Medicine, Palo Alto, CA, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Jubao Duan, PhD</AttrName><Institution>NorthShore University HealthSystem (NUH), Evanston, IL, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Ayman H. Fanous, MD</AttrName><Institution>Washington VA Medical Center and Georgetown University Medical Center, Washington, DC, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Kenneth S. Kendler, MD</AttrName><Institution>Virginia Commonwealth University, Richmond, VA, USA</Institution></Header><Header title="Co-Investigator"><AttrName>John P. Rice, PhD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Alan R. Sanders, MD</AttrName><Institution>NorthShore University HealthSystem (NUH), Evanston, IL, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH67257</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59588</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59571</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59565</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59587</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH60870</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH60879</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59566</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59586</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH61675</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - Genotyping and Analyses"><AttrName>U01 MH79469</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - Genotyping and Analyses"><AttrName>U01 MH79470</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="GAIN The Genetic Association Information Network" url="http://www.fnih.org/index.php?option=com_content&amp;task=view&amp;id=338&amp;Itemid=454"/></StudyURLs><Publications><Publication><Pubmed pmid="16400611"/></Publication><Publication><Pubmed pmid="17728769"/></Publication><Publication><Pubmed pmid="18198266"/></Publication><Publication><Pubmed pmid="18677311"/></Publication><Publication><Pubmed pmid="18813210"/></Publication><Publication><Pubmed pmid="19571809"/></Publication><Publication><Pubmed pmid="19571811"/></Publication><Publication><Pubmed pmid="19571808"/></Publication><Publication><Unparsed>There is 1 publication associated to this study.


Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, Buccola NG, Hale N, Weilbaecher AN, Nertney DA, Olincy A, Green S, Schaffer AW, Smith CJ, Hannah DE, Rice JP, Cox NJ, Martinez M, Mowry BJ, Amin F, Silverman JM, Black DW, Byerley WF, Crowe RR, Freedman R, Cloninger CR, Levinson DF, Gejman PV. 
Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. 
Am J Hum Genet. 2006 Feb; 78(2):315-33. 


</Unparsed></Publication></Publications></StudyInfo><Authority><ICs><IC id="15" name="NHGRI" is_funding_ic="true" is_admin_ic="true"/><IC id="8" name="NIMH" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="PGEJMAN" aid="2" auth="eRA" login="PGEJMAN" fname="Pablo" mname="V." lname="Gejman" email="PGEJMAN@northshore.org"><Role>PI</Role><Organization>NORTHSHORE UNIVERSITY HEALTHSYSTEM</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010617167" aid="1" auth="cit" login="farberg" fname="Gregory" mname="Kyle" lname="Farber" email="farberg@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="9 months"><acknowledgement_statement>Funding support for the Genome-Wide Association of Schizophrenia Study was provided by the National Institute of Mental Health (R01 MH67257, R01 MH59588, R01 MH59571, R01 MH59565, R01 MH59587, R01 MH60870, R01 MH59566, R01 MH59586, R01 MH61675, R01 MH60879, R01 MH81800, U01 MH46276, U01 MH46289 U01 MH46318, U01 MH79469, and U01 MH79470) and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The datasets used for the analyses described in this manuscript were obtained from the database of Genotypes and Phenotypes (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number XXXX. Samples and associated phenotype data for the Genome-Wide Association of Schizophrenia Study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI: Pablo V. Gejman, Evanston Northwestern Healthcare (ENH) and Northwestern University, Evanston, IL, USA).</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_old_cert" gsr_mode_label="Unrestricted access (institution responded that the study is not sensitive without submitting a new Institutional Certification)"/><ConsentGroup uid="318" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

May be used for any genetic studies</Use-Restriction></ConsentGroup><ConsentGroup uid="319" CGType="cg_class_other" title="Schizophrenia and Related Conditions" name="SARC" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Limited to genetic studies of Schizophrenia and related conditions. Related conditions include conditions with evidence of genetic relationships to schizophrenia or schizoaffective disorder, such as acute psychoses, bipolar disorder, MDD, or "Cluster A" personality disorders (schizotypal, schizoid, paranoid).</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="318"><StudyTo study_uid="12358" name="dbGaP Collection: Open Translational Science in Schizophrenia (OPTICS)" accession="phs000887.v1"><ConsentGroupTo uid="1368" name="GRU"/></StudyTo></ConsentGroupLink><ConsentGroupLink cg_uid_from="318"><StudyTo study_uid="20653" name="dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets" accession="phs001254.v1"><ConsentGroupTo uid="2132" name="GRU"/></StudyTo></ConsentGroupLink><ConsentGroupLink cg_uid_from="319"><StudyTo study_uid="20653" name="dbGaP Collection: Psychiatric Genomics Consortium (PGC) dbGaP Datasets" accession="phs001254.v1"><ConsentGroupTo uid="2135" name="DS-SZRD-GSO"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="5387" whole_study_id="5387" phs="000021" v="2" p="1" createDate="2008-09-24T10:42:31-05:00" modDate="2020-09-01T10:21:45-05:00" maxParentChildStudyModDate="2020-09-01T10:21:45-05:00" handle="GAIN_Schizophrenia_v2" num_participants="5066"><StudyInfo accession="phs000021.v2.p1" parentAccession="phs000021.v2.p1"><StudyNameReportPage>http://www.fnih.org/index.php?option=com_content&amp;task=view&amp;id=338&amp;Itemid=454</StudyNameReportPage><StudyNameEntrez>GAIN: Genome-Wide Association Study of Schizophrenia</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><Description>
&lt;p&gt;The goal of the study is to find susceptibility genes for schizophrenia.&lt;/p&gt;   &lt;p&gt;&lt;b&gt;Important links to apply for individual-level data&lt;/b&gt;    &lt;ol&gt;        &lt;li&gt;&lt;a href="GetPdf.cgi?id=phd001063.2" target="_blank"&gt;GAIN Data Access Request Instructions&lt;/a&gt; (read before applying!)&lt;/li&gt;        &lt;li&gt;&lt;a href="http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?view_pdf&amp;stacc=phs000021.v2.p1" target="_blank"&gt;Data Use Certification Requirements (DUC)&lt;/a&gt; (read before applying!)&lt;/li&gt;        &lt;li&gt;&lt;a href="http://view.ncbi.nlm.nih.gov/dbgap-controlled" target="_blank"&gt;Apply here for controlled access to individual level data&lt;/a&gt;&lt;/li&gt;    &lt;/ol&gt;    &lt;/p&gt;     &lt;p&gt;&lt;b&gt;Dataset versioning&lt;/b&gt;&lt;br/&gt;    &lt;ul&gt;   &lt;li&gt;Version 1: European-American (EA) ancestry only&lt;/li&gt;   &lt;li&gt;Version 2: Version 1 plus African-American (AA) ancestry&lt;/li&gt;    &lt;/ul&gt;    &lt;/p&gt;    &lt;p&gt;&lt;b&gt;Consent groups and participant set&lt;/b&gt;&lt;br/&gt;  &lt;ul&gt;      &lt;li&gt;General research use (GRU):  4591 cases and controls (1217 EA cases, 1442 EA controls, 953 AA cases, 979 AA controls)&lt;br/&gt;      This consent group includes a subset of schizophrenia cases and all controls (which overlap with Bipolar study controls      in Bipolar: GRU dataset).&lt;/li&gt;   &lt;li&gt;Schizophrenia and related disorders (SARC): 475 cases (187 EA cases, 288 AA cases)&lt;br/&gt;      This consent group includes a subset of schizophrenia cases.&lt;/li&gt;  &lt;/ul&gt;    &lt;/p&gt;
 </Description><Attributions><Header title="Lead Principal Investigator and Clinical Site PI"><AttrName>Pablo V. Gejman, MD</AttrName><Institution>NorthShore University HealthSystem (NUH), Evanston, IL, USA</Institution></Header><Header title="Statistical Task Force Chair, Clinical Site PI, Clinical Database"><AttrName>Douglas F. Levinson, MD</AttrName><Institution>Stanford University School of Medicine, Palo Alto, CA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Farooq Amin, MD</AttrName><Institution>Emory University, Atlanta, GA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Donald W. Black, MD</AttrName><Institution>University of Iowa Hospitals and Clinics, Iowa City, IA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Nancy G. Buccola, APRN., CNS-BC</AttrName><Institution>Louisiana State University Health Services Center, New Orleans, LA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>William F. Byerley, MD</AttrName><Institution>University of San Franciso, San Francisco, CA, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>C. Robert Cloninger, MD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Robert Freedman, MD</AttrName><Institution>University of Colorado Health Sciences Center, Denver, CO, USA</Institution></Header><Header title="Clinical Site PI"><AttrName>Bryan J. Mowry, MD</AttrName><Institution>Queensland Centre for Mental Health Research, Queensland, Australia</Institution></Header><Header title="Clinical Site PI"><AttrName>Jeremy M. Silverman, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, New York, USA</Institution></Header><Header title="Statistician"><AttrName>Frank Dudbridge, PhD</AttrName><Institution>University of Cambridge, Institute of Public Health, Cambridge, UK</Institution></Header><Header title="Statistician"><AttrName>Peter A. Holmans, PhD</AttrName><Institution>Wales College of Medicine, Cardiff University, Cardiff, Wales, UK</Institution></Header><Header title="Statistician"><AttrName>Maria Martinez, PhD</AttrName><Institution>Institut National de la Sant&#233; et de la Recherche M&#233;dicale (INSERM), Toulouse, France</Institution></Header><Header title="Statistician"><AttrName>Itsik Pe'er, PhD</AttrName><Institution>Columbia University, New York, NY, USA</Institution></Header><Header title="Statistician"><AttrName>Jianxin Shi, PhD</AttrName><Institution>Stanford University School of Medicine, Palo Alto, CA, USA</Institution></Header><Header title="Statistician"><AttrName>Alice Whittemore, PhD</AttrName><Institution>Stanford University School of Medicine, Palo Alto, CA, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Jubao Duan, PhD</AttrName><Institution>NorthShore University HealthSystem (NUH), Evanston, IL, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Ayman H. Fanous, MD</AttrName><Institution>Washington VA Medical Center and Georgetown University Medical Center, Washington, DC, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Kenneth S. Kendler, MD</AttrName><Institution>Virginia Commonwealth University, Richmond, VA, USA</Institution></Header><Header title="Co-Investigator"><AttrName>John P. Rice, PhD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Co-Investigator"><AttrName>Alan R. Sanders, MD</AttrName><Institution>NorthShore University HealthSystem (NUH), Evanston, IL, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH67257</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59588</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59571</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59565</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59587</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH60870</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH60879</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59566</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH59586</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - MGS1 and MGS2 Sample Collections"><AttrName>R01 MH61675</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - Genotyping and Analyses"><AttrName>U01 MH79469</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source - Genotyping and Analyses"><AttrName>U01 MH79470</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="GAIN The Genetic Association Information Network" url="http://www.fnih.org/index.php?option=com_content&amp;task=view&amp;id=338&amp;Itemid=454"/></StudyURLs><Publications><Publication><Pubmed pmid="16400611"/></Publication><Publication><Pubmed pmid="17728769"/></Publication><Publication><Pubmed pmid="18198266"/></Publication><Publication><Pubmed pmid="18677311"/></Publication><Publication><Pubmed pmid="18813210"/></Publication><Publication><Pubmed pmid="19571809"/></Publication><Publication><Pubmed pmid="19571811"/></Publication><Publication><Pubmed pmid="19571808"/></Publication><Publication><Unparsed>There is 1 publication associated to this study.


Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, Buccola NG, Hale N, Weilbaecher AN, Nertney DA, Olincy A, Green S, Schaffer AW, Smith CJ, Hannah DE, Rice JP, Cox NJ, Martinez M, Mowry BJ, Amin F, Silverman JM, Black DW, Byerley WF, Crowe RR, Freedman R, Cloninger CR, Levinson DF, Gejman PV. 
Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. 
Am J Hum Genet. 2006 Feb; 78(2):315-33. 


</Unparsed></Publication></Publications></StudyInfo><Authority><ICs><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="PGEJMAN" aid="2" auth="eRA" login="PGEJMAN" fname="Pablo" mname="V." lname="Gejman" email="PGEJMAN@northshore.org"><Role>PI</Role><Organization>NORTHSHORE UNIVERSITY HEALTHSYSTEM</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011573826" aid="1" auth="cit" login="otawangv" fname="Vivian" mname="" lname="Ota Wang" email="otawangv@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="9 months"><DUC><File uri="dbgapssws.cgi?blob_id=6135&amp;file=get&amp;page=file" filename="GAIN Data Use Certification_04 01 10_final.pdf" md5="06d4614baf08d699a9ff91524db6a4a6" size="231674" modDate="2010-04-26T10:51:31-05:00" content-type="application/pdf"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=6135&amp;file=get&amp;page=file" filename="GAIN Data Use Certification_04 01 10_final.pdf" md5="06d4614baf08d699a9ff91524db6a4a6" size="231674" modDate="2010-04-26T10:51:31-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="18" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="55" dac_name="GAIN" irb-approval-required="No"><Use-Restriction>May be used for any genetic studies.
</Use-Restriction></ConsentGroup><ConsentGroup uid="19" CGType="cg_class_other" title="Schizophrenia and related disorders" name="SARC" dac_uid="55" dac_name="GAIN" irb-approval-required="No"><Use-Restriction>Limited to genetic studies of Schizophrenia and related conditions. Related conditions include conditions with evidence of genetic relationships to schizophrenia or schizoaffective disorder, such as acute psychoses, bipolar disorder, MDD, or "Cluster A" personality disorders (schizotypal, schizoid, paranoid).</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>